![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/16 | |
A61K 9/20 | |||
A61K 9/28 | |||
A61K 31/397 |
(11) | Number of the document | 3129006 |
(13) | Kind of document | T |
(96) | European patent application number | 15735733.6 |
Date of filing the European patent application | 2015-04-08 | |
(97) | Date of publication of the European application | 2017-02-15 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2015/052552 |
Date | 2015-04-08 |
(87) | Number | WO 2015/155711 |
Date | 2015-10-15 |
(30) | Number | Date | Country code |
201461977806 P | 2014-04-10 | US |
(72) |
BOUILLOT, Philippe Michel Rene, CH
REYNAUD, Emeric, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | IMMUNOSUPPRESSANT FORMULATION |
IMMUNOSUPPRESSANT FORMULATION |